NFE2L2 and cancer: Intriguingly, a widely used chemotherapy drug, mitomycin C, becomes more toxic in cancer cells with aberrant NRF2 activation because mitomycin C is transformed into a more toxic form by the enzymes induced by NRF2 [92].